Trading Ideas

Is FibroGen Inc (NASDAQ:FGEN) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, unconventional data sources, expert networks, and get tips from investment bankers and industry insiders. Sure they sometimes fail miserably, but their consensus […] …read more […]

Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 of 2018 due to various reasons. Nevertheless, the data show elite investors’ consensus picks have done well on average over the long-term. The top 20 stocks among hedge funds beat […] …read more […]

“Since 2006, value stocks (IVE vs IVW) have underperformed 11 of the 13 calendar years and when they beat growth, it wasn’t by much. Cumulatively, through this week, it has been a 122% differential (up 52% for value vs up 174% for growth). This appears to be the longest and most severe drought for value […] …read more […]

The market has been volatile in the last few months as the Federal Reserve finalized its rate cuts and uncertainty looms over trade negotiations with China. Small cap stocks have been hit hard as a result, as the Russell 2000 ETF (IWM) has underperformed the larger S&P 500 ETF (SPY) by more than 10 percentage […] …read more […]

Aramco Goes Public, Finally Saudi Arabia took the biggest company in the world public today in the Saudi Arabian exchange, for what logically ended up being the biggest IPO in the world. It sold 3 billion shares at $8.53 a share, raising more than the now-runner-up Alibaba (NYSE:BABA) when it went public in 2014. Since […]The post Market Morning: Aramco Goes Public, Pelosi to Save Democracy, Payrolls Beat, Uber Assaults appeared first on Market Exclusive. …read more […]

Today we will run through one way of estimating the intrinsic value of Momo Inc. (NASDAQ:MOMO) by taking the foreast… …read more […]

(Bloomberg) — Just when it looked like gold’s rally had gotten back on track, the U.S. payrolls report came along.The number of jobs added to the economy jumped 266,000 last month, the most since January, according to a government report Friday that topped all estimates in a Bloomberg survey calling for 180,000 jobs.Gold has struggled to sustain recent rallies as resilient U.S. economic data and bets on progress toward a U.S.-China trade deal limit demand for the metal as a haven. That weakens the case for more cuts on U.S. borrowing costs, further damping the appeal of the non-interest-bearing precious …read more […]

The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September 30. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund portfolios. Our extensive […] …read more […]

U.S. Food and Drug Administration staffers reviewing Correvio Pharma Corp’s heart drug said on Friday they did not believe the benefits offered by the therapy outweighed its risks, sending the company’s shares down 14%. The drug, Brinavess, approved in several other counties including Europe and Canada, aims to correct erratic heart rhythm in the upper chambers of the heart due to a condition known as atrial fibrillation or AFib. Although Correvio has provided sufficient evidence of the drug’s benefit, Brinavess comes with “serious liabilities” including low blood pressure, irregular heartbeats in the lower heart chambers, and death, the …read more […]

Contrary to what you may have heard, physical retail isn’t dead. True, some retailers have struggled mightily in the wake of rapid industry disruption by Amazon (Nasdaq: AMZN) and the rise of e-commerce. But there are plenty of investment opportunities available to you when it comes to retail stocks.
Perhaps no activity belongs to the fabric of what it is to be America more than shopping does. Whether done in traditional brick-and-mortar stores or through online portals, Americans will continue to shop in any foreseeable future. So expect retail stocks to continue producing profits for you for many years to come.

What …read more […]

Stock futures edged up Friday morning ahead of the release of the Labor Department’s November jobs report. …read more […]

OPEC will remove 340,000 barrels a day while non-OPEC producers will cut production by 160,000 barrels, the report said. …read more […]

Unfortunately for some shareholders, the NetSol Technologies (NASDAQ:NTWK) share price has dived 30% in the last… …read more […]

UCB SA said on Friday its experimental plaque psoriasis drug produced better results compared to AbbVie Inc’s blockbuster drug, Humira, in reducing the severity of the disease. UCB’s drug, bimekizumab, also met the main goal of clearing or almost clearing the skin of plaques or rashes in a late-stage study, as assessed by an investigator, according to the Belgium-based company. AbbVie’s Humira is the world’s top selling drug and treats rheumatoid arthritis and psoriasis. …read more […]

Q1 2020 Comtech Telecommunications Corp Earnings Call …read more […]